 - must agree that the participant and the participants partner will each use acceptable methods of contraception for at least 2 weeks prior to Day 1 and continue until at least 6 months after last dose of study medication, or longer if dictated by local regulations for a female participant who is of childbearing potential or male participant with female sexual partner who is of childbearing potential 